Private Market View

Accro Bioscience

Suzhou, China · Founded 2017 · Privately Held (backing)

Last price · $/share
Implied valuation
$161.0M
Total raised
$62.0M
Last round
What is Accro Bioscience worth?
$161.0Mlast known valuation
Free account
See the evidence behind this price
  • ·The complete investor list — 10 names
  • ·Watchlist + deal alerts for Accro Bioscience
  • ·The full record, as it builds
Create free account
No card required

Funding history

No rounds on record

No funding rounds for Accro Bioscience are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

How Accro Bioscience's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Accro Bioscience, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked

What is Accro Bioscience worth?
Accro Bioscience's last known valuation is $161.0M.
How much has Accro Bioscience raised?
Accro Bioscience has raised $62.0M in total funding across its recorded rounds.